Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA
- 16 January 2017
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 31 (6) , 757-769
Abstract
Synthetic cannabinoids (SCs) have rapidly proliferated as recreational drugs, and may present a substantial health risk to vulnerable populations. However, information on possible effects of long-term use is sparse. This study compared acute and residual effects of the popular indazole carboxamide SC compounds AB-PINACA and AB-FUBINACA in adolescent rats with ∆9-tetrahydrocannabinol (THC) and control treatments. Albino Wistar rats were injected (i.p.) with AB-PINACA or AB-FUBINACA every second day (beginning post-natal day (PND) 31), first at a low dose (0.2 mg/kg on 6 days) followed by a higher dose (1 mg/kg on a further 6 days). THC-treated rats received equivalent doses of 6 × 1 mg/kg and 6 × 5 mg/kg. During drug treatment, THC, AB-PINACA, and AB-FUBINACA decreased locomotor activity at high and low doses, increased anxiety-like behaviours and audible vocalisations, and reduced weight gain. Two weeks after dosing was completed, all cannabinoid pre-treated rats exhibited object recognition memory deficits. These were notably more severe in rats pre-treated with AB-FUBINACA. However, social interaction was reduced in the THC pre-treated group only. Six weeks post-dosing, plasma levels of cytokines interleukin (IL)-1α and IL-12 were reduced by AB-FUBINACA pre-treatment, while cerebellar endocannabinoids were reduced by THC and AB-PINACA pre-treatment. The acute effects of AB-PINACA and AB-FUBINACA were broadly similar to those of THC, suggesting that acute SC toxicity in humans may be modulated by dose factors, including inadvertent overdose and product contamination. However, some lasting residual effects of these different cannabinoid receptor agonists were subtly different, hinting at recruitment of different mechanisms of neuroadaptation.Keywords
Funding Information
- National Health and Medical Research Council
This publication has 78 references indexed in Scilit:
- Acute Prosocial Effects of Oxytocin and Vasopressin When Given Alone or in Combination with 3,4-Methylenedioxymethamphetamine in Rats: Involvement of the V1A ReceptorNeuropsychopharmacology, 2013
- Patterns of synthetic cannabinoid use in AustraliaDrug and Alcohol Review, 2012
- Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findingsAddiction, 2012
- Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activityBiochemical Pharmacology, 2012
- Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2Pediatrics, 2011
- 1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in miceDrug and Alcohol Dependence, 2011
- When Is the Hippocampus Involved in Recognition Memory?The Journal of Neuroscience, 2011
- Cannabinoid CB2receptors: a therapeutic target for the treatment of inflammatory and neuropathic painBritish Journal of Pharmacology, 2008
- Prolonged Recovery Rate of CB1 Receptor Adaptation after Cessation of Long-Term Cannabinoid AdministrationMolecular Pharmacology, 2006
- Chronic exposure to Δ9-tetrahydrocannabinol downregulates oxytocin and oxytocin-associated neurophysin in specific brain areasMolecular and Cellular Neuroscience, 2006